Business Context and Reporting Period
This Form 8-K Current Report was filed by TopSpin Medical, Inc. (not My Size, Inc.) on February 5, 2009, covering events occurring on February 1, 2009. The company is incorporated in Delaware and maintains its principal executive offices in Lod, Israel.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial event reported is a capital raise:
- Investment Amount: NIS 900,000 (approximately $222,000).
- Equity Issued: 120,000,000 shares of common stock.
- Options Granted: Options to purchase up to 58,064,516 additional shares.
- Option Terms: Exercise price of 0.01 NIS per share; exercisable for four years from issuance.
Material Changes
The material change reported is the entry into a definitive investment agreement with Asher Shmulewitz. This transaction significantly increases the company's share count and provides immediate liquidity of approximately $222,000, subject to Tel Aviv Stock Exchange approval.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard regulatory disclosures. The transaction is contingent upon approval by the Tel Aviv Stock Exchange. All shares issued are subject to transfer restrictions under U.S. and Israeli securities laws and were issued pursuant to Regulation S.
Investor Verification Checklist
- Verify the approval status of the transaction by the Tel Aviv Stock Exchange.
- Confirm the exact dilution impact of issuing 120,000,000 shares plus options for 58,064,516 shares on existing shareholders.
- Review the company's latest 10-K or 10-Q to understand the context of this capital raise relative to current cash reserves and burn rate.
- Confirm the identity of the investor, Asher Shmulewitz, and any potential related-party transaction disclosures.